MYC and lung cancer: Zhao and colleagues constructed a murine lung cancer model using HepG2 cells with RNAi-silenced c-MYC [338], and demonstrated that MYC expression was dramatically decreased, while transwell chamber cell migration assays showed significantly reduced migration of cells with c-MYC silenced, relative to controls [338].